We need your mantras for a new project! Share with us.
We are aware of and actively working on an issue where the first page/opening posts of threads with more than one page are not able to be accessed. We hope to have this resolved soon. Thank you for your patience!
Exp. Elacestrant Promising for Pre-Treated HR+, HER2- MBC
moderators
Posts: 10,281
Experimental Elacestrant Shows Promise for Pre-Treated Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer
December 8, 2021
Experimental elacestrant offered better progression-free survival than standard hormonal therapy for post-menopausal women and men diagnosed with metastatic, hormone receptor-positive, HER2-negative breast cancer that had grown during treatment with hormonal therapy and a CDK4/6 inhibitor. Read more...
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your profile.